U.S. markets close in 57 minutes
  • S&P 500

    4,176.74
    -45.12 (-1.07%)
     
  • Dow 30

    33,381.58
    -441.87 (-1.31%)
     
  • Nasdaq

    14,027.42
    -133.93 (-0.95%)
     
  • Russell 2000

    2,235.61
    -51.84 (-2.27%)
     
  • Crude Oil

    71.64
    +0.60 (+0.84%)
     
  • Gold

    1,770.60
    -4.20 (-0.24%)
     
  • Silver

    25.93
    +0.08 (+0.31%)
     
  • EUR/USD

    1.1876
    -0.0034 (-0.29%)
     
  • 10-Yr Bond

    1.4450
    -0.0660 (-4.37%)
     
  • GBP/USD

    1.3820
    -0.0104 (-0.74%)
     
  • USD/JPY

    110.1450
    -0.0860 (-0.08%)
     
  • BTC-USD

    35,419.50
    -2,312.33 (-6.13%)
     
  • CMC Crypto 200

    874.29
    -65.66 (-6.99%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Phreesia (PHR) in Focus: Stock Moves 5.5% Higher

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Phreesia, Inc. PHR was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company for the company—as the stock is now up 30.5% in the past one-month time frame.

The company has seen one positive estimate revision in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Phreesia. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Phreesia currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative. 

Phreesia, Inc. Price

Phreesia, Inc. Price
Phreesia, Inc. Price

Phreesia, Inc. price | Phreesia, Inc. Quote

A better-ranked stock in the Medical Info Systems is Omnicell, Inc. OMCL, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Omnicell, Inc. (OMCL) : Free Stock Analysis Report
 
Phreesia, Inc. (PHR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research